• Investment summary:

    Arcinova is an independent pharmaceutical contract research and development business which services a range of international life science companies, helping them to progress their projects through the drug development process efficiently and with minimum risk.

    A £750,000 loan from the North East Growth Plus Fund, managed by FW Capital, has helped Arcinova to deliver its plans for significant growth.

  • Total investment:
  • Total FW Capital investment:
  • Investment type:
  • Fund:
    North East Growth Plus Fund
  • Executives:
    Keith Charlton

North East Growth Plus Fund